BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Leukocyte
,
Pharmacogenetics
,
Doxorubicin
,
rs2300478
,
SLC12A1
,
Ischemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
GLR 1
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for GLR 1
Explore Curated Studies Results
Literature
Most Relevant Literature
The mechanism of AMPA receptor subunit GluR1 in electroacupuncture treatment of acute spinal cord in…
Deletion of AMPA receptor GluA1 subunit gene (Gria1) causes circadian rhythm disruption and aberrant…
Sevoflurane Preconditioning Downregulates GRIA1 Expression to Attenuate Cerebral Ischemia-Reperfusio…
NETO2-GluK2 interaction contributes to postoperative pain hypersensitivity through inducing PKCĪ³ act…
Influence of electroacupuncture on the expression of AMPA receptor subunit GluR1 in the spinal injur…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients
Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With La…
Evaluation of GLR2007 for Advanced Solid Tumors
Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast…
Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ